Best Healthcare Research Agencies in Mexico
Compare top healthcare research agencies in Mexico for 2026. Find the right partner for verified HCP panels, patient insights, and clinical market intelligence.
Quick answer
For large-scale, data-intensive pharmaceutical strategy, IQVIA; for regional fieldwork and panel access in Latin America, Fine Research; for specialized patient and clinician primary research, Global Vox Populi; and for brand-centric consumer-health insights, Kantar.
Securing accurate insights within the Mexican healthcare environment requires a nuanced understanding of local regulatory frameworks, diverse provider systems, and specific patient demographics. Decision-makers in the pharmaceutical, medtech, and public-health sectors must work through these complexities to inform product development, market access, and brand performance effectively.
This assessment profiles established healthcare research agencies in Mexico, evaluating their capabilities in primary data collection, analytical rigor, and specialized audience access. Understanding these providers is essential for procurement and insights teams aiming to mitigate risk and protect data integrity in 2026. Choosing the right partner depends on whether your requirement is for deep clinical data sets, broad consumer brand tracking, or targeted, high-incidence professional recruitment.
Best Healthcare Research Agencies in Mexico: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale pharmaceutical market intelligence | 88.0 |
| 2 | Fine Research | Regional healthcare fieldwork in Latin America | 80.5 |
| 3 | Global Vox Populi | Targeted healthcare professional and patient recruitment | 80.0 |
| 4 | Ipsos Healthcare | Longitudinal health system tracking | 79.5 |
| 5 | Kantar | Brand equity and consumer health tracking | 79.0 |
| 6 | Psyma Latina | Full-service qualitative healthcare fieldwork | 77.0 |
| 7 | Brain – Brand Investigation | Innovative market intelligence solutions | 66.0 |
| 8 | LAC Intermarketing | Pharmaceutical cultural adaptation and strategy | 61.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Healthcare professionals, patients, pharmacy/wholesalers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Fine Research | Healthcare professionals, B2B, consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | HCPs, patients, caregivers, payers, providers | License and registration verification with rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 64,224 healthcare professionals; 46,435 nurses and allied health professionals; 706,675 patient profiles (in Mexico; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos Healthcare | Patients, healthcare professionals, consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Consumers, patients, healthcare professionals | Qubed AI anti-fraud system | Not stated on pages reviewed | Not published | Not published | Not published |
| Psyma Latina | Physicians, patients, healthcare decision-makers | Not published | ISO certified | Not published | Not published | Not published |
| Brain – Brand Investigation | Consumers, patients | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| LAC Intermarketing | Healthcare stakeholders, pharmaceutical decision-makers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| Fine Research | ● | ● | – | ● | ● | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos Healthcare | ● | ● | – | ● | ● | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| Psyma Latina | ● | ● | – | ● | – | ● |
| Brain – Brand Investigation | – | – | – | ● | – | ● |
| LAC Intermarketing | ● | – | – | ● | – | ● |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their demonstrated ability to maintain rigor, compliance, and specific audience access in the Mexican healthcare environment.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This evaluates the agency's depth of experience in the Mexican health sector, including knowledge of local physician referral patterns, public and private health system structures, and the specific regulatory environment governing pharmaceutical and medical device research in the region. |
| Compliance, Certifications and Security | 20 | This measures adherence to ISO 20252, ISO 9001, and ISO/IEC 27001 standards, alongside compliance with HIPAA, GDPR, and local Mexican data protection laws. It assesses how firms handle sensitive patient data and report adverse events per international industry codes. |
| Target Audience Reach | 15 | This assesses the ability to access specific, often low-incidence, healthcare audiences in Mexico, including specialists, hard-to-reach patients, and key opinion leaders. High scores reflect proprietary, well-profiled panels rather than reliance on rented or open-market sample sources. |
| Research Quality | 10 | This evaluates the rigour of sampling, questionnaire design, and fieldwork execution. It looks for evidence of data cleaning processes, such as identity fingerprinting, trap questions, and fraud detection, to make sure the final insights are reliable for high-stakes business decisions. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This assesses the range of research methods offered, from traditional focus groups and in-depth interviews to advanced digital survey tools, mobile-assisted studies, and ethnography, making sure the firm can match the methodology to the specific research objective. |
| Analytical Capability | 5 | This scores the firm's capacity to synthesize raw fieldwork data into actionable, business-ready insights. It looks for the ability to provide clear recommendations, market segments, and strategic guidance rather than just presenting raw, uninterpreted data sets. |
| Client Service and Speed | 5 | This evaluates the responsiveness, project management proficiency, and turnaround times for research projects in Mexico. It considers how firms adapt to project scope changes and communicate clearly throughout the lifecycle of the fieldwork process. |
| Pricing and Feasibility Transparency | 5 | This measures the clarity and honesty of the firm regarding project feasibility, incidence rates, and pricing models. High-scoring firms provide upfront, realistic expectations about what can be achieved within specific timelines and budget constraints. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in Mexico
IQVIA: best for large-scale pharmaceutical market intelligence
Strongest fitGlobal pharmaceutical firms requiring large-scale clinical and commercial data insights.
IQVIA combines proprietary data sets with advanced analytics to support life sciences organizations in Mexico. Its local office provides commercial strategy, real-world evidence, and clinical development solutions aimed at accelerating innovation and improving patient outcomes.
The agency integrates data, technology, and analytics to optimize clinical trials and commercial execution. Its focus is on providing end-to-end intelligence that connects market insights with clinical trial management.
Scorecard: 88.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.0 |
Core services
- Clinical Development: Full-service clinical trials, site identification, and biostatistical support for pharmaceutical and biotech assets.
- Market Intelligence: Commercial strategy and market analytics using proprietary healthcare databases and non-identified patient records.
- Functional Outsourcing: Flexible FSP models providing customized deployment of expertise for R&D and commercial operations.
Strengths
- Data Scale: Access to petabytes of proprietary data and vast healthcare databases to inform market and clinical decisions.
- Technology Integration: Use of AI-driven platforms like IQVIA.ai to predict market trends and accelerate clinical development pathways.
Innovation and technology
- Predictive Analytics: Life Science Models and agentic AI platforms that assist in forecasting market opportunities and clinical outcomes.
Impact on businesses
- Commercial Success: Helps pharmaceutical companies maximize asset probability of success in complex, competitive healthcare environments.
Why it may fit your brief
IQVIA suits large organizations needing comprehensive, data-heavy analysis. Smaller research projects may find its infrastructure and service model more aligned with extensive, long-term pharmaceutical engagements.
Fine Research: best for regional healthcare fieldwork in Latin America
Strongest fitInternational research agencies needing a reliable, regional fieldwork partner in Mexico.
Fine Research focuses exclusively on fieldwork in the healthcare, consumer, and B2B sectors across Latin America. It maintains local teams and operations, emphasizing methodological rigour and cultural expertise in the Mexican market.
The agency acts as a partner for global research firms, managing complex projects with a focus on high-quality data collection through proprietary panels.
Scorecard: 80.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.5 |
Core services
- Quantitative Fieldwork: Large-scale quantitative data collection, including online surveys and tracking studies across the region.
- Qualitative Recruitment: Highly specialized qualitative recruitment, including focus groups and IDIs conducted in local facilities.
- Project Management: End-to-end support from proposal development through to final delivery for international research partners.
Strengths
- Regional Scale: Owns operational infrastructure and local teams across Latin American markets, protecting consistent execution.
- Healthcare Focus: Primary area of expertise is healthcare, with staff trained in pharmacovigilance and international project management standards.
Innovation and technology
- Proprietary Panels: Maintains the largest HCP panel in Latin America, allowing for targeted access to medical specialists.
Impact on businesses
- Operational Excellence: Helps global agencies execute research consistently while adapting to local cultural and operational realities.
Why it may fit your brief
Fine Research is ideal for those who need a dedicated fieldwork partner that understands the nuances of the Latin American health environment. It is a highly specialized partner for operational execution.
Global Vox Populi: best for targeted healthcare professional and patient recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitResearch teams requiring high-quality, verified HCP or patient data for critical clinical or commercial decisions.
Global Vox Populi provides primary market research through its own proprietary healthcare professionals and patient panels. Its operations in Mexico are built on direct recruitment through professional associations and verified medical registries, protecting high-quality data for pharmaceutical and health-system studies.
The company maintains a focus on low-incidence targeting and feasibility verification, supporting a range of methodologies from hospital studies to medtech research. Its infrastructure is designed to handle sensitive data with strict adherence to international standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Mexico
64,224 panellists
- Primary & General26,316
- Internal Medicine Subspecialties5,436
- Acute, Peri-operative & Critical Care4,782
- Diagnostic & Laboratory4,528
- Women's & Reproductive Health4,392
- Surgical Specialties3,976
Nurses and allied health panel, in Mexico
46,435 panellists
- Registered Nurses15,743
- Advanced Practice Nurses907
- Licensed / Practical / Enrolled Nurses2,805
- Nursing Support (Aides / HCAs)1,832
- Midwives1,407
- Pharmacists & Pharmacy Techs2,760
Patient panel, in Mexico
706,675 patient profiles
- Aesthetics & Cosmetic236,716
- Cardiovascular45,339
- Women's Health38,454
- Dermatology36,437
- Endocrinology & Metabolic35,439
- Preventive & Vaccine-preventable32,802
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Mexico
1,245 panellists
- Provider: Access & Administrative Roles797
- Payer: Access & Coverage Roles448
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 7/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Primary Research Recruitment: Execution of complex studies using nurses and allied health and payers and providers panels.
- Data Collection Methods: Full-service fieldwork including focus groups, in-depth interviews, CATI, CAPI, and online survey hosting on proprietary platforms.
- Data Quality Assurance: Implementation of identity fingerprinting, geo-checks, and automated removal of fraudulent completes prior to data delivery.
Strengths
- Proprietary Panel Depth: Direct ownership of 64,224 HCPs and 706,675 patient profiles in Mexico, enabling granular targeting across therapeutic areas.
- Rigorous Verification: Clinical members are validated against license records and re-verified on a rolling basis to maintain panel integrity.
- Regulatory Compliance: Adherence to ISO 9001, ISO 20252, ISO/IEC 27001, and HIPAA, with adverse event reporting following BHBIA guidance.
Innovation and technology
- Panel Profiling Technology: Advanced profiling using 45 to 140 data points per member to support precise, low-incidence study requirements.
- Data Security Infrastructure: Deployment of device and identity fingerprinting to detect and mitigate bot activity and straight-lining in real-time.
Impact on businesses
- Strategic Decision Support: Provides actionable evidence for market access and product positioning through verified, high-quality respondent data.
- Risk Mitigation: Minimizes research bias and data errors, protecting reliable foundations for high-stakes pharmaceutical and clinical investments.
Panel details: see the healthcare professionals panel.
Why it may fit your brief
It is a suitable choice for briefs demanding strict regulatory compliance and specialized, non-rented sample sources. For projects requiring broader, general consumer brand equity tracking unrelated to healthcare, a generalist agency may offer different efficiencies.
Ipsos Healthcare: best for longitudinal health system tracking
Strongest fitFirms requiring longitudinal trend analysis and patient experience insights.
Ipsos Healthcare delivers research and advisory services in Mexico, focusing on the pharmaceutical, biotech, and medical device industries. It offers patient journey mapping, physician engagement studies, and brand performance tracking.
The firm uses various methodologies, including social media analysis and survey data, to provide insights into healthcare systems, market trends, and patient experiences.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Market Understanding: Strategy and understanding of healthcare markets using quantitative and qualitative data sources.
- Brand Tracking: Brand health measurement and performance monitoring within the pharmaceutical and medical sectors.
- Patient and Physician Research: Engagement studies and journey mapping for both patients and healthcare professionals.
Strengths
- Global Trends Insight: Access to extensive longitudinal data, such as the Global Health Service Report, to benchmark health system performance.
- Methodological Variety: Combines surveys, polls, social media, and qualitative communities to provide a holistic view of market dynamics.
Innovation and technology
- AI-Driven Insights: Application of AI to synthesize large datasets and deliver actionable insights for faster decision-making.
Impact on businesses
- Informed Decisions: Helps clients make smarter decisions by providing accurate information on society, markets, and patient opinions.
Why it may fit your brief
Ipsos is well-suited for clients needing to understand broad health system trends. Those with highly specific, niche therapeutic research needs might find more focused expertise in specialist primary research boutique agencies.
Kantar: best for brand equity and consumer health tracking
Strongest fitCompanies needing broad brand tracking and consumer sentiment insights in the health sector.
Kantar offers research solutions in Mexico focused on brand strategy, communication testing, and market segmentation. It uses proprietary panels and advanced analytics to help health-sector clients understand patient and consumer behaviors.
The agency emphasizes data quality through its anti-fraud technology and global research standards. Its approach centers on connecting consumer understanding with business growth objectives.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Brand Strategy: Brand equity studies and valuation using large-scale consumer data sets to guide marketing and product development.
- Survey Solutions: Custom survey services and global omnibus studies across multiple markets with fast turnaround times.
- Audience Activation: Digital audience validation and targeting to fuel addressable audiences via ad platforms.
Strengths
- Global Reach: Access to millions of panelists globally and locally, supported by proprietary panel management and anti-fraud AI.
- Advanced Anti-Fraud: Uses Qubed AI and deep neural networks to detect fraudulent activity and protect data integrity in surveys.
Innovation and technology
- Qubed AI Technology: Machine learning system that processes survey features in milliseconds to protect data from fraudulent completes.
Impact on businesses
- Brand Growth: Delivers insights that help brands increase ROI and optimize communication strategies across channels.
Why it may fit your brief
Kantar is ideal for consumer-focused health brands. Clients needing highly specific clinical research or deep, expert-led HCP studies might prefer a provider with a more concentrated medical panel infrastructure.
Psyma Latina: best for full-service qualitative healthcare fieldwork
Strongest fitClients needing tailored, full-service qualitative and quantitative research support for pharma products.
Psyma Latina operates with a focus on pharmaceutical and medical technology research in Mexico. Its approach combines deep local market knowledge with international research standards to support product life-cycle strategies.
The agency emphasizes a “Business Issue First” methodology, providing customized research solutions from study design through to insights consulting.
Scorecard: 77.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.0 |
Core services
- Full-Service Research: End-to-end research support including study design, fieldwork, data analysis, and insights consulting.
- Market Potential Assessment: Evaluation of market potential for healthcare products throughout their entire life cycle.
- Qualitative Fieldwork: Expertise in qualitative techniques to uncover patient and physician motivations.
Strengths
- Specialized Expertise: Dedicated team focused on pharma, medtech, and dental sectors with deep regional market experience.
- ISO Certification: Commitment to rigorous research standards and quality management in international market research.
Innovation and technology
- Insights Consulting: Translation of raw data into strategic marketing recommendations using specialized industry knowledge.
Impact on businesses
- Marketing Strategy: Supports marketing decisions with meaningful insights derived from full-service research solutions.
Why it may fit your brief
Psyma Latina provides a strong balance of local presence and international standard adherence. It is an excellent fit for those requiring a personalized partnership rather than a high-volume, automated research solution.
Brain – Brand Investigation: best for innovative market intelligence solutions
Strongest fitCompanies looking for tech-forward, innovative research methods in the Mexican market.
Brain – Brand Investigation provides full-service research and strategic consulting in Mexico. It is known for integrating advanced technologies like virtual reality into its market intelligence gathering processes.
The agency serves both local and international clients, focusing on understanding market trends and consumer behavior through modern analytical frameworks.
Scorecard: 66.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 6/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 66.0 |
Core services
- Market Intelligence: Full-service research providing insights into market trends and consumer behavior.
- Strategic Consulting: Consulting services that translate market intelligence into actionable business strategies.
- Advanced Technology Research: Use of AI and virtual reality to capture deeper consumer insights.
Strengths
- Technological Innovation: Early adoption of virtual reality and AI to differentiate research methodologies from traditional approaches.
- Local Expertise: Deep understanding of the Mexican market environment, serving both local and international clients.
Innovation and technology
- AI and VR Integration: Applying emerging technologies to collect and analyze complex consumer and market data.
Impact on businesses
- Strategic Decision-Making: Helps clients work through market changes with innovative research formats and strategic recommendations.
Why it may fit your brief
Brain is a good fit for projects requiring creative, tech-enabled data collection. For strictly clinical or highly regulated pharmaceutical trials, a firm with a longer history of specialized medical compliance might be prioritized.
LAC Intermarketing: best for pharmaceutical cultural adaptation and strategy
Strongest fitGlobal pharmaceutical companies needing local strategic adaptation of their commercial plans.
LAC Intermarketing provides strategic research and consulting, with a historical focus on the pharmaceutical sector. It specializes in helping international organizations adapt their strategies to the Mexican market context.
The agency is recognized for its industry knowledge and ability to work through the intersection of global corporate mandates and local cultural market dynamics.
Scorecard: 61.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 6/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 61.0 |
Core services
- Strategic Consulting: Consulting on how to align global pharmaceutical strategies with local Mexican market requirements.
- Cultural Adaptation: Research-based insights to adapt communications and products to the local Mexican cultural context.
- Market Research: Strategic research focused on pharmaceutical industry opportunities and challenges.
Strengths
- Industry Knowledge: Deep historical focus on the pharmaceutical industry, providing specialized insight for international clients.
- Local-Global Bridge: Strong capability to translate and adapt complex global strategies for local execution in Mexico.
Innovation and technology
- Strategic Alignment: Developing frameworks to make sure pharmaceutical strategies are effectively implemented across different market realities.
Impact on businesses
- Market Success: Enables international healthcare organizations to succeed by making sure their strategies are culturally and operationally relevant.
Why it may fit your brief
LAC Intermarketing is best for strategic consulting and cultural adaptation. For projects requiring high-volume data collection or large-scale quantitative fieldwork, a more research-heavy fieldwork agency might be more efficient.
How HCP and patient verification actually works in Mexico
Verify respondent identity through professional registry cross-referencing and rolling re-validation procedures.
Professional Credential Validation
For healthcare professionals, firms should cross-reference names, license numbers, and specialties against official medical registries or government databases. Ask for evidence of the verification process, such as how often records are updated and what happens when a credential cannot be confirmed. Relying solely on self-reported data is a major risk, as it allows non-qualified individuals to participate in research. Professional agencies will document their verification workflow, showing how they filter out invalid entries before they ever touch your survey data.
Identity and Fraud Detection
Modern agencies use digital fingerprinting to identify unique users and detect bot activity or fraudulent attempts to join panels. Protect the provider uses device-level tracking and geo-location checks to verify that the respondent is located in Mexico as claimed. If a provider cannot explain their anti-fraud technology or how they prevent duplicate accounts, the integrity of the data collected is compromised. Always request a summary of the data-cleaning protocols applied to your specific project before final delivery.
Consent and Privacy Compliance
Check that the agency uses a double opt-in process for all participants, which confirms the intent of the respondent and protects valid contact information. Granular consent, where participants agree to specific uses of their data, is essential for compliance with local data protection laws. Ask how the firm manages revocable consent and if they can provide documentation demonstrating that their panel members have agreed to be contacted for research purposes. This is especially important for sensitive patient-level data collection.
Data Quality Scoring
High-performing firms use completion-quality scoring to track respondent behavior during the survey, such as straight-lining or speeding. Ask for the criteria used to disqualify responses. A good provider will remove responses that fail these checks, making sure that only high-quality data is included in your analysis. If an agency cannot explain their quality-control logic, you risk making critical business decisions based on noise or dishonest feedback from low-quality panel members who are not genuinely interested in your research.
How to choose the right provider in Mexico
Evaluate healthcare research agencies based on their ability to combine local regulatory compliance with specialized respondent access.
- Define Research Objectives: Clarify if the need is for broad market sentiment or granular clinical insights. This determines whether you need a large-scale data provider or a boutique primary research firm.
- Assess Panel Ownership: Prioritize firms that own and manage their own panels. This protects direct control over respondent verification and data quality compared to rented sample pools.
- Check Regulatory Standards: Confirm the agency follows international standards like ISO 20252 and HIPAA. Compliance is mandatory for pharmaceutical and medical research in the Mexican market.
- Verify Data Cleaning: Ask specifically about their fraud detection protocols. Reliable firms will have documented processes for identifying and removing bot traffic and fraudulent survey completions.
- Review Analytical Capabilities: Make sure the partner provides actionable insights rather than just raw data. Look for teams that can synthesize findings into clear, business-focused recommendations.
Questions to ask before you commission
- How do you verify the clinical credentials of your healthcare professional panelists in Mexico?
- What specific anti-fraud and data-cleaning protocols do you apply to this project?
- How do you protect compliance with both international health-data standards and local Mexican privacy laws?
- Can you provide a breakdown of your panel size for the specific therapeutic areas or specialties I need?
- What is your process for handling adverse event reporting during the course of a study?
- How does your team translate raw data into strategic recommendations for commercial decision-making?
Common pitfalls to avoid
- Relying on Generalist Panels: Using broad consumer panels for specialized healthcare research often leads to poor data quality and lack of medical expertise, resulting in unreliable insights.
- Ignoring Data Compliance: Failing to verify that a provider meets ISO or HIPAA standards can lead to significant legal and reputational risks when handling patient-level health data.
- Lack of Verification: Assuming that panel members are who they claim to be without checking their medical credentials against official registries is a common cause of poor research outcomes.
- Ignoring Feasibility Check: Proceeding with a study without a confirmed feasibility assessment often results in missed deadlines and under-recruitment, especially for low-incidence specialties.
What a feasibility check should include
A comprehensive feasibility check must validate audience availability and incidence rates before fieldwork begins.
Audience Availability
Confirm if the agency has enough active, profiled members in your specific target group. This prevents delays and makes sure the study can actually be completed.
Incidence Rate Accuracy
Ask for realistic incidence rate estimates for your target population. High-incidence groups are cheaper to reach, while rare conditions require more specialized, time-intensive recruitment.
Timeline Realism
Make sure the feasibility report includes a realistic timeline for reaching your required sample size. Avoid firms that promise immediate results for hard-to-reach medical groups.
Budget Alignment
Verify that the quoted feasibility aligns with your project budget. Clear upfront communication prevents unexpected costs during the fieldwork process.
Conclusion
Choosing the right partner from the available healthcare research agencies in Mexico requires aligning your project’s specific needs with the provider’s core strengths. For large-scale pharmaceutical data and market intelligence, global firms like IQVIA offer extensive data sets and analytical depth. For regional fieldwork and consistent data collection across Latin America, firms like Fine Research provide the operational scale necessary for complex projects.
If your requirement is for highly targeted primary research involving clinicians, patients, or payers, firms such as Global Vox Populi offer the specialized, verified panel infrastructure needed to protect data integrity and compliance. Use the scorecard provided to weigh each agency against your project’s requirements for compliance, audience reach, and analytical depth. Always prioritize providers that demonstrate transparent, verifiable processes for panel management and data quality to make sure your research delivers reliable, actionable insights.
Planning research in Mexico? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research agencies in Mexico?
The top agencies are those that specialize in health and life sciences rather than general consumer research. Key players include IQVIA for large-scale data and clinical intelligence, Fine Research for regional fieldwork execution, Global Vox Populi for primary research with proprietary healthcare and patient panels, and Psyma Latina for full-service qualitative and quantitative research.
How do I select a healthcare research partner in Mexico?
Selection should be based on the partner's ability to verify respondent credentials, adhere to international health-data regulations like HIPAA or GDPR, and provide access to specialized panels. Evaluate their data-cleaning protocols, their experience in the Mexican market, and their ability to provide actionable insights rather than just raw survey data.
Does IQVIA operate in Mexico?
Yes, IQVIA has extensive operations in Mexico, including a dedicated office in Mexico City. They provide pharmaceutical companies and life-sciences organizations with market intelligence, real-world evidence, and commercial strategy services, using their global data infrastructure alongside local expertise.
What is the role of market research in the Mexican pharmaceutical industry?
Market research is essential for understanding physician prescribing patterns, patient journeys, and market access dynamics. It informs product development, brand positioning, and commercial strategies, helping pharmaceutical companies work through the complex public and private health systems in Mexico while protecting regulatory compliance and effective engagement.
Are there specialized clinical research agencies in Mexico?
Yes, several agencies specialize in healthcare and clinical research. Firms like IQVIA focus on clinical trials and development, while others like Global Vox Populi and Psyma Latina provide primary research that supports the clinical and commercial lifecycle of healthcare products through specialized, verified respondent panels.
How does healthcare market research in Mexico differ from other regions?
Research in Mexico requires deep knowledge of the specific healthcare system structure, which includes both public and private providers. Cultural nuances in patient communication and physician engagement are significant, as is the need to work through regional regulations for data privacy and clinical research that may differ from those in the US or Europe.
What services do Mexican healthcare research firms provide?
Services include quantitative and qualitative fieldwork, patient journey mapping, physician engagement studies, brand tracking, real-world evidence generation, and strategic consulting. These firms use various methods such as focus groups, in-depth interviews, digital surveys, and advanced analytics to provide insights for health-sector clients.
How can I protect data quality for my healthcare research?
Data quality is protected by using providers with proprietary, verified panels rather than rented samples. You should require identity fingerprinting, automated fraud detection, and manual verification of respondent credentials against medical registries. Always ask for evidence of the agency's quality-control protocols before commissioning a study.